BHF CRC Announces appointment of new Clinical Lead

We are delighted to announce the appointment of Prof Rod Stables to the role of Clinical Lead for the BHF CRC.

This vital role will provide the essential clinical leadership to support the planning and delivery of world-class clinical research in all aspects of cardiovascular disease.

Prof Stables is a consultant cardiologist and is the Director of the Cardiac Catheterisation Laboratories at the Liverpool Heart and Chest Hospital (LHCH), UK—a specialist cardiothoracic unit and, in terms of procedure volume, one of the largest cardiac units in Europe. He was the Chair of the Academic and Research Committee at the British Cardiovascular Society and holds academic appointments at the University of Liverpool and Imperial College, London.

His clinical interests include coronary intervention including emergency Primary Percutaneous Coronary Intervention (PPCI), TAVI, and non-surgical septal reduction in hypertrophic cardiomyopathy. He founded the Clinical Trials and Evaluation Unit at the Royal Brompton Hospital and led its initial flagship ventures.

His research interests are focused on the democratisation of clinical research, seeking to simplify the design, conduct and reporting of clinical trials, and other forms of outcomes analysis. This is exemplified in the conduct of the HEAT-PPCI trial (the largest ever single-centre trial and the only study to recruit 100% of eligible patient presenting with the clinical syndrome of interest).

Prof Stables’ term as the BHF CRC Clinical Lead role will commence immediately until the end of May 2021.